SHIRE PHARMACEUTICALS IRELAND LTD has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Israel and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are ZYMENEX AS, THROMBOGENICS NV and PORTAGE PHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Israel | 4 | |
#3 | Australia | 3 | |
#4 | New Zealand | 3 | |
#5 | United States | 3 | |
#6 | Japan | 2 | |
#7 | Republic of Korea | 2 | |
#8 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Enzymes | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Nilsson Stefan | 10 |
#2 | Weigelt Cecilia | 6 |
#3 | Andersson Claes | 6 |
#4 | Fogh Jens | 6 |
#5 | Hyden Pia | 5 |
#6 | Percel Phillip J | 4 |
#7 | Vishnupad Krishna S | 4 |
#8 | Moller Christer | 4 |
#9 | Bettman Marie J | 4 |
#10 | Hensley Dan L | 4 |
Publication | Filing date | Title |
---|---|---|
CN105233276A | A process for concentration of a polypeptide |